Endovia Health Sciences, Inc. EDVA
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 96.50K | 654.50K | 1.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 96.50K | 654.50K | 1.64M |
| Cost of Revenue | -- | -- | 496.70K | 972.60K | 1.66M |
| Gross Profit | -- | -- | -400.20K | -318.10K | -27.10K |
| SG&A Expenses | -- | -- | 14.24M | 18.82M | 12.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 14.73M | 19.79M | 13.90M |
| Operating Income | -- | -- | -14.64M | -19.14M | -12.27M |
| Income Before Tax | -- | -- | -24.35M | -30.56M | -25.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -24.35 | -30.56 | -25.40 |
| Earnings from Discontinued Operations | -- | -- | -885.60K | -504.80K | -504.80K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -25.23M | -31.07M | -25.90M |
| EBIT | -- | -- | -14.64M | -19.14M | -12.27M |
| EBITDA | -- | -- | -14.63M | -18.96M | -11.99M |
| EPS Basic | -- | -- | -45.77 | -67.94 | -64.10 |
| Normalized Basic EPS | -- | -- | -20.16 | -34.45 | -31.43 |
| EPS Diluted | -- | -- | -45.77 | -67.94 | -64.10 |
| Normalized Diluted EPS | -- | -- | -20.16 | -34.45 | -31.43 |
| Average Basic Shares Outstanding | -- | -- | 2.03M | 1.86M | 1.65M |
| Average Diluted Shares Outstanding | -- | -- | 2.03M | 1.86M | 1.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |